Cell cycle dynamics analysis of drug-tolerant persister cells in non-small cell lung cancer

Molecular-targeted therapy remains effective in cancer treatment; however, drug resistance inevitably arises after prolonged administration for several years. Drug-tolerant persister cells (DTPs), which are subpopulations of cells derived from drug-sensitive cells that develop tolerance after short-term exposure (lasting days or weeks) to drugs, have gained substantial attention. However, the specific characteristics of DTPs remain unclear as they encompass a diverse cell population, although they generally exhibit low proliferative potential. Therefore, analysis of cell cycle fluctuations during and after the formation of DTPs is expected to elucidate DTPs characteristics and contribute to future therapies. Here, we introduced the Fucci probe into the PC9 cell line to create PC9-Fucci to observe dynamic cell cycle variations during and after the DTPs formation process. The results showed that during the formation of DTPs, the majority of cells showed red fluorescence and were arrested in the G1 phase, whereas a small number of S-phase cells showed green fluorescence. Furthermore, some cells proliferated after the DTPs phase under drug-free medium and drug-containing medium culture conditions. These results indicate cell cycle diversity, with the majority of cells exhibiting arrested cell cycle during the formation of DTPs, whereas others existed in the S phase. In addition, cell cycle diversity occurs not only in the process of DTPs formation but also in subsequent processes.

Authors

Institutions

Publication Details

Journal
Biochemical and Biophysical Research Communications
Published
2025-05-27
DOI
https://doi.org/10.1016/j.bbrc.2025.152107
Citations
2
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
3.04
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cell cycle dynamics analysis of drug-tolerant persister cells in non-small cell lung cancer

Yasuo M Tsutsumi, Yuya Haga, Akihide Nishimura, Kazuma Higashisaka et al.
2 citations
Biochemical and Biophysical Research Communications
Lung Cancer Treatments and Mutations
3.04
article

Cell cycle dynamics analysis of drug-tolerant persister cells in non-small cell lung cancer

Yasuo M Tsutsumi, Yuya Haga, Akihide Nishimura, Kazuma Higashisaka, Suzuno Tanahashi, Mo Zhou
article en
2 citations

Abstract

Molecular-targeted therapy remains effective in cancer treatment; however, drug resistance inevitably arises after prolonged administration for several years. Drug-tolerant persister cells (DTPs), which are subpopulations of cells derived from drug-sensitive cells that develop tolerance after short-term exposure (lasting days or weeks) to drugs, have gained substantial attention. However, the specific characteristics of DTPs remain unclear as they encompass a diverse cell population, although they generally exhibit low proliferative potential. Therefore, analysis of cell cycle fluctuations during and after the formation of DTPs is expected to elucidate DTPs characteristics and contribute to future therapies. Here, we introduced the Fucci probe into the PC9 cell line to create PC9-Fucci to observe dynamic cell cycle variations during and after the DTPs formation process. The results showed that during the formation of DTPs, the majority of cells showed red fluorescence and were arrested in the G1 phase, whereas a small number of S-phase cells showed green fluorescence. Furthermore, some cells proliferated after the DTPs phase under drug-free medium and drug-containing medium culture conditions. These results indicate cell cycle diversity, with the majority of cells exhibiting arrested cell cycle during the formation of DTPs, whereas others existed in the S phase. In addition, cell cycle diversity occurs not only in the process of DTPs formation but also in subsequent processes.

Biochemical and Biophysical Research CommunicationsVol. 775
Museum of Japanese Art Yamato Bunkakan (JP), The University of Osaka (JP)
Good health and well-being
Openalex Percentile: Top 9%
Lung Cancer Treatments and Mutations
3.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.